On November 16, 2009, Boehringer Ingelheim reported that late-stage trials showed that Flibanserin promoted sexual desire and increased the number of "satisfying sexual events" in women suffering from abnormally low libido.
read more : Flibanserin - Wikipedia, the free encyclopedia


































LinkBack URL
About LinkBacks
Reply With Quote
Bookmarks